Gene Therapy for Inherited Deafness Shows Lasting Hearing Restoration
A multicenter study found a one-time treatment targeting the OTOF gene restored hearing in most participants, with effects lasting up to 2.5 years.
A multicenter study found a one-time treatment targeting the OTOF gene restored hearing in most participants, with effects lasting up to 2.5 years.
The company highlights progress in its SENS-501 and GJB2-GT clinical programs, recent financing, and a leadership transition.
New research shows while overall traffic to low-credibility health sites is low, it is highly concentrated among seniors, particularly those who lean right politically.
A new study suggests noninvasive prenatal screening can detect cytomegalovirus, a common cause of permanent hearing loss in newborns.
Read MoreA deep transfer learning AI model predicted spoken language outcomes in children one to three years after cochlear implantation with 92% accuracy.
Read MoreAustralian researchers have identified key genetic and molecular drivers of long COVID using large-scale global datasets and AI, offering a path toward more precise diagnosis, risk prediction, and targeted treatments.
Read MoreA new peer-reviewed study shows that Phonak Infinio Sphere hearing aids with AI-based noise reduction reduce cognitive load and listening effort while improving speech understanding in noisy environments.
Read MoreThe system’s developers think the technology could one day help users of hearing aids to filter their soundscapes without the need to manually direct the AI’s “attention.”
Read MoreA major longitudinal study of more than 3,300 teens finds that by age 18, one in eight adolescents shows signs of probable noise-induced hearing damage and over 6% have sensorineural hearing loss.
Read MoreResearchers at Macquarie University have discovered that the human brain rapidly adapts to the acoustic characteristics of spaces, with speech understanding optimized in environments with a moderate amount of reverberation.
Read MoreA new digital reconstruction study shows that middle-ear hearing loss becomes severe when fluid occupies about half of the ear cavity, offering a non-invasive marker for diagnosing and staging otitis media with effusion.
Read MoreA new study finds that humans’ ability to focus on a single voice in noisy environments—known as selective attention—appears not to originate in subcortical structures like the brainstem or auditory nerve.
Read MoreDespite advances in hearing technology and satisfaction rates, new Eurotrak UK 2025 data reveals that many people still avoid getting hearing instruments for the same reasons as in years past.
Read MoreAn eight-year study underscores the critical need for universal newborn screening for congenital cytomegalovirus (cCMV), revealing that one-third of related hearing loss cases develop after birth and would be missed without early detection programs.
Read MoreA University of Oklahoma researcher is studying how children with cochlear implants use sensory feedback from their mouths and tongues to develop speech, exploring whether enhancing oral motor training could improve language outcomes.
Read MoreUpdated pivotal trial results show that Regeneron’s investigational gene therapy DB-OTO led to rapid, clinically meaningful, and sustained hearing improvements in nearly all children with OTOF-related profound genetic hearing loss, with some achieving normal hearing and improved speech development.
Read MoreA new study has identified how electrical charges in the inner ear trigger TMPRSS3-related hearing loss—and found that a common drug may help prevent it.
Read MoreThe therapy targets mutations in the CLIC5 gene, which affect hair cell stability and lead to progressive hearing and balance impairments.
Read More